FLEX LNG Ltd. (FLNG)

Akoya Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	354.55	356.35	371.02	347.92	343.45	164.46
Revenue Growth (YoY)	-3.86%	-3.96%	6.64%	1.30%	108.83%	37.09%
Cost of Revenue	76.15	73.29	70.04	65.93	64.57	40.7
Gross Profit	278.4	283.06	300.99	281.99	278.88	123.77
Selling, General & Admin	9.79	9.79	10.47	9.15	7.89	6.3
Operating Expenses	85.29	85.27	83.83	81.37	77.72	48.15
Operating Income	193.11	197.79	217.16	200.62	201.16	75.62
Interest Expense	-92.82	-82.75	-90.44	3.09	-37.82	-66.99
Interest & Investment Income	4.4	4.47	4.87	2.01	0.04	0.33
Currency Exchange Gain (Loss)	0.75	-	-	-	-	-
Other Non Operating Income (Expenses)	-1.43	-1.06	-1.23	-1.46	0.14	-0.77
EBT Excluding Unusual Items	104.01	118.45	130.36	204.24	163.51	8.19
Other Unusual Items	-0.64	-0.64	-10.24	-16.1	-1.21	-
Pretax Income	103.37	117.82	120.12	188.14	162.3	8.19
Income Tax Expense	0.19	0.13	0.08	0.1	0.1	0.08
Net Income	103.19	117.68	120.04	188.04	162.21	8.11
Net Income to Common	103.19	117.68	120.04	188.04	162.21	8.11
Net Income Growth	-24.53%	-1.96%	-36.16%	15.93%	1901.30%	-52.23%
Shares Outstanding (Basic)	54	54	54	53	53	54
Shares Outstanding (Diluted)	54	54	54	54	53	54
Shares Change (YoY)	0.10%	0.08%	0.86%	0.34%	-1.72%	0.05%
EPS (Basic)	1.91	2.19	2.24	3.53	3.04	0.15
EPS (Diluted)	1.91	2.18	2.22	3.51	3.04	0.15
EPS Growth	-24.50%	-1.80%	-36.75%	15.46%	1929.16%	-51.67%
Free Cash Flow	188.1	182.8	175.03	219.88	-51.09	-602.09
Free Cash Flow Per Share	3.48	3.38	3.24	4.11	-0.96	-11.09
Dividend Per Share	3.000	3.000	3.000	3.000	2.300	0.400
Dividend Growth	-	-	-	30.44%	475.00%	100.00%
Gross Margin	78.52%	79.43%	81.12%	81.05%	81.20%	75.26%
Operating Margin	54.47%	55.51%	58.53%	57.66%	58.57%	45.98%
Profit Margin	29.10%	33.02%	32.35%	54.05%	47.23%	4.93%
Free Cash Flow Margin	53.05%	51.30%	47.18%	63.20%	-14.88%	-366.09%
EBITDA	256.68	263.7	282.89	272.84	270.99	117.47
EBITDA Margin	72.40%	74.00%	76.24%	78.42%	78.90%	71.42%
D&A For EBITDA	63.57	65.9	65.73	72.22	69.83	41.85
EBIT	193.11	197.79	217.16	200.62	201.16	75.62
EBIT Margin	54.47%	55.51%	58.53%	57.66%	58.57%	45.98%
Effective Tax Rate	0.18%	0.11%	0.07%	0.05%	0.06%	1.03%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q